Disrupted Vitamin D Metabolism in Hepatocellular Carcinoma: Free and Bioavailable 25(OH)D as Novel Biomarkers of Hepatic Reserve and Clinical Risk
Molecules · 2026
DOI: 10.3390/molecules31020273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Joško Osredkar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Chemistry and Biochemistry, University Medical Centre Ljubljana, Zaloška c 2, 1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Vitamin D. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Although total 25-hydroxyvitamin D (25(OH)D) measurements may not accurately reflect functional vitamin D status, vitamin D deficiency is common in hepatocellular carcinoma (HCC). The contribution of altered vitamin D-binding protein (VDBP) and albumin to impaired bioavailability is poorly characterized in liver cancer.
Methods
We measured total, free, and bioavailable 25(OH)D, VDBP, and albumin in 46 HCC patients and 87 healthy controls during winter and summer. Correlations with Child–Pugh score, Barcelona Clinic Liver Cancer (BCLC) stage, and disease aetiology were evaluated.
Results
HCC patients exhibited significantly lower VDBP (177.3 ± 237.0 vs. 239.9 ± 141.9 mg/L, p < 0.001) and albumin (35.9 ± 5.4 vs. 48.0 ± 3.9 g/L, p < 0.001) compared to winter controls. Total 25(OH)D was lower in HCC (39.3 ± 22.1 nmol/L) versus summer controls (75.0 ± 22.8 nmol/L, p < 0.001) but comparable to winter controls (p = 0.061). HCC patients lacked seasonal variation in vitamin D fractions, unlike the controls. VDBP negatively correlated with free (ρ = −0.606, p < 0.001) and bioavailable 25(OH)D (ρ = −0.541, p < 0.001). Child–Pugh score correlated positively with BCLC stage (ρ = 0.378, p = 0.012) and inversely with albumin (ρ = −0.565, p < 0.001).
Conclusions
Free and bioavailable vitamin D are profoundly compromised in HCC, reflecting impaired hepatic synthetic function and systemic inflammation. These fractions may serve as novel metabolic biomarkers superior to total 25(OH)D for assessing vitamin D deficiency and guiding individualized supplementation strategies in patients with liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Chemistry and Biochemistry, University Medical Centre Ljubljana, Zaloška c 2, 1000 Ljubljana, Slovenia.
- Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia.
- Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.
- Department of Endocrinology, Diabetes and Metabolic Disease, University Medical Centre Ljubljana, Zaloška c 2, 1000 Ljubljana, Slovenia.
- Department of Gastroenterology, University Medical Centre Ljubljana, Zaloška c 2, 1000 Ljubljana, Slovenia.
ORCID-Profile: Joško Osredkar, Matej Rakusa, Aleš Jerin, Darko Siuka
Zitieren
APA
Osredkar, J., Rakusa, M., Jerin, A., Štabuc, B., Zaplotnik, M., Štupar, S., & Siuka, D. (2026). Disrupted Vitamin D Metabolism in Hepatocellular Carcinoma: Free and Bioavailable 25(OH)D as Novel Biomarkers of Hepatic Reserve and Clinical Risk. Molecules. https://doi.org/10.3390/molecules31020273
Vancouver
Osredkar J, Rakusa M, Jerin A, Štabuc B, Zaplotnik M, Štupar S, et al. Disrupted Vitamin D Metabolism in Hepatocellular Carcinoma: Free and Bioavailable 25(OH)D as Novel Biomarkers of Hepatic Reserve and Clinical Risk. Molecules. 2026. doi:10.3390/molecules31020273
BibTeX
@article{Osredkar2026,
author = {Osredkar, Joško and Rakusa, Matej and Jerin, Aleš and Štabuc, Borut and Zaplotnik, Martin and Štupar, Saša and Siuka, Darko},
title = {Disrupted Vitamin D Metabolism in Hepatocellular Carcinoma: Free and Bioavailable 25(OH)D as Novel Biomarkers of Hepatic Reserve and Clinical Risk},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31020273}
}
EUVIMED